Tammaro Paolo
Faculty of Life Sciences, University of Manchester, Manchester, UK.
Br J Pharmacol. 2009 Jun;157(4):551-3. doi: 10.1111/j.1476-5381.2009.00204.x.
Vascular ATP-sensitive potassium (K(ATP)) channels (Kir6.1/SUR2B) are regulated by both cell metabolism and chemical transmitters. They are the target for a number of vasodilators and vasoconstrictors whose mechanisms of action involve activation of protein kinase A (PKA) and protein kinase C (PKC), respectively. The article by Orie et al. in this issue of the BJP sheds new light on the (opposing) role of protein phosphatases in the regulation of this ion channel activity. Their data suggest that calcineurin, a Ca(2+)-dependent protein phosphatase, modulates Kir6.1/SUR2B by inhibiting PKA-dependent phosphorylation of the channel. This novel mechanism may provide a modulation opposing the action of vasodilators on the K(ATP) channel.
血管ATP敏感性钾(K(ATP))通道(Kir6.1/SUR2B)受细胞代谢和化学递质的双重调节。它们是多种血管舒张剂和血管收缩剂的作用靶点,这些药物的作用机制分别涉及蛋白激酶A(PKA)和蛋白激酶C(PKC)的激活。Orie等人在本期《英国药理学杂志》上发表的文章为蛋白磷酸酶在调节该离子通道活性中的(相反)作用提供了新的线索。他们的数据表明,钙调神经磷酸酶,一种Ca(2+)依赖性蛋白磷酸酶,通过抑制通道的PKA依赖性磷酸化来调节Kir6.1/SUR2B。这种新机制可能提供一种与血管舒张剂对K(ATP)通道作用相反的调节作用。